Cargando…
COVID-19 and the liver: What do we know so far?
The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on public health and healthcare. The pandemic surge and resultant lockdown have affected the standard-of-care of many medical conditions and diseases. The initial uncertainty and fear of cross transmission of severe a...
Autores principales: | Nasa, Prashant, Alexander, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173343/ https://www.ncbi.nlm.nih.gov/pubmed/34131467 http://dx.doi.org/10.4254/wjh.v13.i5.522 |
Ejemplares similares
-
Expiratory Muscles of Respiration and Weaning Failure: What do We Know So Far?
por: Majeed, Nimisha Abdul, et al.
Publicado: (2023) -
Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022) -
COVID-19 and Myocarditis: What Do We Know So Far?
por: Pirzada, Ashar, et al.
Publicado: (2020) -
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
COVID-19 and liver diseases, what we know so far
por: Elnaggar, Mohamed, et al.
Publicado: (2022)